Amgen Inc. (AMGN)

Nasdaq · Healthcare · Drug Manufacturers - General
$435.64-0.15%As of 2026-11-22 · USD
Last session low $434.51Last session high $445.49
52-week low $312.3952-week high $483.99
Market cap
$235.64B
Sector
Healthcare
P/E (TTM)
25.3x
Dividend yield
2.31%
Next earnings
2027-02-02 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)42.5In the neutral range (30 to 70)
MACD (12, 26, 9)3.72Below its signal line (8.57); histogram -4.86
Bollinger %B (20, 2)-4%Below the lower band (437.48 to 479.48)
SMA 20458.48Price is 5.0% below
SMA 50430.50Price is 1.2% above
SMA 200382.45Price is 13.9% above
ATR (20)2.60% of priceAverage true range per day
52-week position72%In the upper part of the 312.39 to 483.99 range

About Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Latest fiscal yearEnded 2025-12-31: revenue of $36.75B and an operating margin of 24.7%.
Next earnings reportExpected on 2027-02-02 (the date is an estimate).

More in Drug Manufacturers - General